Last reviewed · How we verify

NCT04357002

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

Status unknown Phase 4 Last updated 22 April 2020
What this trial tests

Phase 4 trial testing intravenous tranexamic acid in Myomectomy in 180 participants. Status unknown.

Timeline
30 April 2020
Primary endpoint
1 October 2020
15 October 2020

Quick facts

Lead sponsorCairo University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment180
Start date30 April 2020
Primary completion1 October 2020
Estimated completion15 October 2020

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Eligibility, female only, with Myomectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of the present study is to evaluate safety and efficacy of intravenous tranexamic acid versus vaginal dinoprostone in reducing intraoperative blood loss during abdominal myomectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of intravenous tranexamic acid

Trials testing the same drug.

Other recruiting trials for Myomectomy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04357002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing